Clinical Trial Update: Study to Assess the Efficacy and Safety of SKI3246 in Subjects With Non-Constipation Irritable Bowel Syndrome [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the efficacy and safety of SKI3246 in non-constipation irritable bowel syndrome has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome

Drugs mentioned

• SKI3246 (SKI3246)

Snippet

Sponsor: SK Chemicals Co., Ltd. | Conditions: Non-constipation Irritable Bowel Syndrome | Phase 2 | Status: COMPLETED